cardiac arrest - search results
If you're not happy with the results, please do another search
Research highlights “strikingly low” use of public defibrillators in cardiac arrest
Defibrillators are being used in just one in 10 cardiac arrests where they are available, according to research presented at the British Cardiovascular Society...
Women more likely to experience long-term anxiety after cardiac arrest
More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men, according to research presented at the...
Black, low-income, pregnant women more likely to experience cardiac arrest when hospitalised for delivery
A retrospective cohort study investigating the rate of maternal characteristics associated with, and survival following, cardiac arrest during delivery hospitalisation, has found that older,...
Sudden cardiac arrest data collected in ESCAPE-NET project to improve prevention and treatment
Primary care visits rise sharply in the weeks immediately preceding a sudden cardiac arrest, according to results from the ESCAPE-NET project. The project is...
Algorithm could enhance prevention of sudden cardiac arrest
Researchers have developed a clinical algorithm that distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
The findings, Journal of the American...
Patients more likely to survive a cardiac arrest in the operating room than the...
Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospital discharge than those who had a...
Medtronic leads pilot programme to address disparities in sudden cardiac arrest care
Medtronic has announced a pilot programme with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA), a condition...
ESC president urges vigilance over signs of cardiac arrest following Christian Eriksen’s collapse at...
The president of the European Society of Cardiology (ESC) has called for greater awareness of the signs of cardiac arrest and how to respond,...
Research programme to probe causes of unexplained cardiac arrest
A research programme into understanding the underlying causes of unexplained cardiac arrest has received significant backing from the British Heart Foundation (BHF).
The four-year project,...
ACC partners with AED device company for cardiac arrest alliance
The American College of Cardiology (ACC) and automated external defibrillator (AED) technology start-up HeartHero have formed an alliance aimed at making a “significant impact”...
Study shows “out-of-hours” cardiac arrest leads to considerably diminished access to community AEDs
A new study from New Zealand, just published in the New Zealand Medical Journal, has revealed that automated external defibrillators (AEDs) in the community...
AHA provides US$14 million for research into arrhythmias and sudden cardiac arrest
The American Heart Association has awarded research grants of more than US$14 million to four scientific teams to create a new research network focused...
Making a case for cardiovascular genetic testing in patients who survive an unexplained cardiac...
Sudden cardiac arrest remains a major cause of death among young people. Babken Asatryan outlines his research into the genetic basis of the disease,...
Long-term survival worse for black survivors of in-hospital cardiac arrest
Black people who survive cardiac arrest during hospitalisation have lower odds of long-term survival compared with similar white survivors, according to new research published...
European Sudden Cardiac Arrest network will look at gender-based prevention and treatment
Researchers will use a European network of 90,000 patients, including 20,000 DNA samples, to look at different approaches for prevention and treatment of sudden...
Cardiac arrest survival increases with bystanders use of automated external defibrillator
Survival from cardiac arrest doubled when a bystander stepped in to apply an automated external defibrillator (AED) before emergency responders arrived, according to new...
New findings on effects of xenon and hypothermia on cardiac arrest
NeuroproteXeon has announced the publication of a second finding from a randomised, controlled phase II trial of inhaled xenon and oxygen combined with hypothermia...
People reluctant to use public defibrillators to treat cardiac arrest
A study led the University of Warwick, Coventry, UK, has suggested that people are reluctant to use public access defibrillators (AEDs) to treat cardiac...
Caucasians have a higher incidence of an out-of-hospital cardiac arrest but risk of death...
There is a lack of sufficient data about the effect of racial differences on outcomes following an out-of-hospital cardiac arrest. Therefore, Karuppiah Arunachalam and...
US government funding dwindles for cardiac arrest research
National Institutes of Health (NIH) funding to conduct cardiac arrest research has dwindled in the last decade, and is a fraction of what the...
Obamacare health insurance expansion linked to fewer cardiac arrests
A sudden catastrophic loss of heart function, or cardiac arrest, occurred significantly less among adults who acquired health insurance via the Affordable Care Act...
App directs first responders to cardiac arrest three minutes before ambulance
A novel smartphone application (app) has been developed that can direct first responders to cardiac arrest victims more than three minutes before the emergency...
European network created to find sudden cardiac arrest causes and treatments
A European network—the European Sudden Cardiac Arrest network (ESCAPE-NET)—has been created to find sudden cardiac arrest causes and compare treatments. In Europe, around 20%...
MADIT S-ICD global study enrols first patient to assess sudden cardiac arrest prevention in...
Boston Scientific has initiated a worldwide study (MADIT S-ICD) that will evaluate the survival benefit of patients treated with the Emblem MRI Subcutaneous Implantable...
New research indicates “harmless” painkillers are associated with an increased risk of cardiac arrest
According to a study published in European Heart Journal–Cardiovascular Pharmacotherapy, painkillers that are traditionally considered harmless by the general public are associated with increased...
Automated external defibrillator accessibility: Barrier during cardiac arrest
There is just a one in five chance that a potentially life-saving automated external defibrillator (AED) will be nearby when someone experiences cardiac arrest...
Black Americans are at greater risk for sudden cardiac arrest than white Americans
Black Americans are more likely to experience sudden cardiac arrest and at a much earlier age than their white compatriots, according to research published in Circulation.
Air pollution from wildfires may increase risk for cardiac arrest
Exposure to fine particle air pollution during wildfires may increase risk for cardiac arrest and other acute heart problems, particularly in the elderly, a new study has found.
Baku 2015 equips European Games with Zoll AED Plus to treat sudden cardiac arrest
Eighty AED Plus units will be distributed among the mobile medical teams and be available across all Baku 2015 venues.
Bystander CPR helps cardiac arrest survivors return to work
In the largest study to date to examine return to work after cardiac arrest, researchers studied 4,354 patients in Denmark who were employed before they suffered out-of-hospital cardiac arrests between 2001 and 2011.
Physically active middle-aged adults have low risk of sudden cardiac arrest
A review of 1,247 sudden cardiac arrest cases involving men and women ages 35-65 revealed that 63 cases (5%) were associated mainly with sports activities.
Epinephrine may do more harm than good for cardiac arrest patients
For patients in cardiac arrest, administering epinephrine may increase the overall likelihood of death or debilitating brain damage, according to a study published in the Journal of the American College of Cardiology.
Vitamin D deficiency increases poor brain function after cardiac arrest
Vitamin D deficiency increases the risk of poor brain function after sudden cardiac arrest by seven-fold, according to research presented at Acute Cardiovascular Care 2014 by Jin Wi.
Heart rate may predict survival and brain function in comatose cardiac arrest survivors
A study has found that patients with sinus bradycardia during therapeutic hypothermia had a 50-60% lower mortality rate at 180 days than those with no sinus bradycardia.
Use of device for chest compressions compared to manual CPR does not improve short-term...
A study presented at the American Heart Association Scientific Sessions (16-20 November, Dallas, USA) has shown that mechanical chest compressions in combination with defibrillation during ongoing compressions provided no improved four-hour survival vs. manual cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest.
No relationship between seizure and sudden cardiac arrest in most patients with epilepsy
Seizure in patients with epilepsy may not be a trigger of sudden cardiac arrest (SCA). Eric Stecker, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, USA, and colleagues, from the Cedars-Sinai Heart Institute, Los Angeles, USA, reported in a study recently published in Circulation Arrhythmia and Electrophysiology.
Out of hospital cardiac arrest survival just 7%
Survival for out-of-hospital cardiac arrest is just 7%, according to research presented at ESC congress 2013 by Xavier Jouven, Hopital Georges Pompidou, Paris, France and Wulfran Bougouin, Paris, France.
Odds of surviving sudden cardiac arrest increase at fitness facilities
A new study published online in the Journal of the American College of Cardiology has found that people experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early cardio-pulmonary resuscitation and access to an automated external defibrillator (AED), among other factors
Heart Rhythm Society and Association of Black Cardiologists launch 10-City Arrest the Risk campaign...
The Heart Rhythm Society and the Association of Black Cardiologists are working in conjunction to help reduce the incidence of sudden cardiac arrest among African Americans through a new campaign titled 10-City Arrest the Risk.
Minnesota Timberwolves star Ricky Rubio teams up with Medtronic Foundation to save young lives...
Now with the help of Rubio, the HeartRescue Project is unveiling the latest life-saving innovation, an interactive online experience called the "Save-A-Life Simulator".
HRS launches Arrest the Risk campaign to overcome the barriers to proper diagnosis and...
Sudden cardiac arrest (SCA), commonly mistaken for a heart attack, is one of the leading causes of death in the United States each year,...
Majority of Americans unaware of effective treatment options to protect against sudden cardiac arrest,...
The survey has shown that 75% of Americans are unaware that an implantable cardioverter defibrillator (ICD) is an effective treatment option to protect those at risk of SCA.
FDA approves first subcutaneous implantable defibrillator for patients at risk of sudden cardiac arrest
The S-ICD System (Boston Scientific) sits below the skin without the need of leads to be placed into the heart. This leaves the heart and blood vessels untouched, offering patients an alternative to transvenous implantable cardioverter defibrillators (ICDs).
ICDs have contributed to the reduction in ventricular fibrillation out of hospital cardiac arrests
Researchers in The Netherlands have found that the use of implantable cardioverter defibrillators (ICDs) may be partly responsible for the reduction in the number of ventricular fibrillation out of hospital cardiac arrests.
HRS educational patient video on Sudden Cardiac Arrest, Bronze winner at Telly Awards
The Sudden Cardiac Arrest Patient Education DVD is the Society’s first-ever educational DVD developed as a resource specifically for patients with SCA and part...
Heart Rhythm Society named Bronze winner at the 33rd Annual Telly Awards for its...
The Sudden Cardiac Arrest Patient Education DVD is the Society's first-ever educational DVD developed as a resource specifically for patients at risk of sudden cardiac arrest and part of the Society's annual SCA awareness initiatives.
Philips launches campaign to raise awareness on sudden cardiac arrest
Royal Philips Electronics has launched the Save Lives website (www.SaveLives.net), an online campaign to inform people about sudden cardiac arrest and to empower them...
Heart Rhythm Society launches atrial fibrillation and sudden cardiac arrest awareness campaign
The Heart Rhythm Society (HRS) has launched a Boston citywide awareness campaign to increase knowledge about symptoms, warning signs and available treatment options for atrial fibrillation and sudden cardiac arrest.
Medtronic Foundation launches online “Save-a-Life Simulator” to promote bystander response for cardiac arrest
The Medtronic Foundation's HeartRescue Project has produced an interactive, online experience, the "Save-a-Life Simulator," to promote proper and timely bystander response to sudden cardiac arrest (SCA).
Philips launches HeartStart FR3 automated external defibrillator for sudden cardiac arrest victims
According to the company, the HeartStart FR3 significantly reduces deployment time by eliminating steps to help responders start delivery of the right therapy-cardiopulmonary or defibrillation- on the patient faster.
Automated external defibrillators failures connected to deaths from cardiac arrest
More than 1,000 cardiac arrest deaths over 15 years are connected to the failure of automated external defibrillators (AEDs), according to a study published in Annals of Emergency Medicine.
Adrenaline shows positive results in cardiac arrest treatment
Spontaneous circulation was restored three times more commonly with adrenaline (23.5%) than with saline placebo (8.4%) after cardiac arrest treatment, according to a study to be published in the journal Resuscitation.
New study shows remarkably high survival rates of sudden cardiac arrest at traditional and...
Survival at exercise facilities was 50%, compared with 36% observed for sudden cardiac arrest occurring in non-exercise public indoor locations. The study was presented at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions
Medtronic Foundation invests US$15 Million in multistate project to reduce sudden cardiac arrest deaths
The goal of the HeartRescue Project is to improve out-of-hospital cardiac arrest survival rates by at least 50% in five years, within five pilot states in USA.
ESC 2022: Guidelines call for public engagement in tackling sudden cardiac death
New guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have been published today in the European...
The evolution of cardiac care in the wake of COVID-19
David E Albert, founder and chief medical officer of AliveCor, considers the impact of the COVID-19 pandemic on the monitoring and of management of...
Zoll and Cardiac Science join forces on AED delivery
Zoll Medical, which manufactures medical devices and related software solutions, has signed a definitive agreement to purchase Cardiac Science, a provider of automated external...
New guidelines on ventricular arrhythmias and sudden cardiac death
The American College of Cardiology (ACC), along with the American Heart Association (AHA) and the Heart Rhythm Society (HRS) has published new guidelines for...
AF Symposium 2017: Use of intracardiac echocardiography is a “viable option” for Amplatzer Amulet...
Intracardiac echocardiograpy (ICE) facilitates a high success implant rate of the Amplatzer Amulet left atrial appendage (LAA) occluder (St Jude Medical/Abbott) as well as...
Medtronic receives CE mark for three MRI-compatible cardiac resynchronisation therapy defibrillators
The three cardiac resynchronisation therapy defibrillators (CRT-Ds) are approved for 3 Tesla magnetic resonance imaging scans. These devices are the first and only CRT-Ds approved for this level of MRI, according to a company release.
Boston Scientific welcomes new guidance on the use of cardiac technologies for patients with...
In the updated Technology Appraisal, people with ventricular arrhythmias are eligible for an ICD, which can help prevent cardiac arrest in those who have previously survived a life-threatening arrhythmia. In people with heart failure, CRT can improve life expectancy and quality of life.
Study confirms the value of Cambridge Heart’s MTWA test as a predictor of life-threatening...
At a median follow-up time of 22 months, patients with an abnormal MTWA test were 11 times more likely to experience a major arrhythmic cardiac event than patients with a normal MTWA result.
FDA Advisory Panel recommends expanded indication for Medtronic cardiac resynchronisation therapy with defibrillator (CRT-D)...
FDA's Circulatory Systems Devices Advisory Panel determined that the overall clinical benefits of Medtronic cardiac resynchronisation therapy with implantable cardioverter defibrillator (CRT-D) devices outweigh the risks in treating certain mildly symptomatic heart failure patients.
LifeVest wearable defibrillator reduces total mortality after cardiac revascularisation, study shows
Survival curves showed an 80% reduction in total mortality at 90 days for LifeVest patients as compared to non LifeVest patients post percutaneous coronary intervention, with 90 day mortality of 2% for LifeVest patients versus 10% for non-LifeVest patients.
Camm: “The true incidence of sudden cardiac death in USA and Europe is unknown”
John Camm, St Georges University of London, United Kingdom, overviewed the incidence of sudden cardiac death in Europe and USA at the European Heart Rhythm Association (EHRA)-Europace Congress in Madrid, Spain (26-29 June 2011)
Cameron to spend US$107 million on FDA trial and manufacture of implantable cardiac defibrillator
The S-ICD system (Cameron) is the only implantable defibrillator that does not require electrical wires in the heart. This system is implanted using a completely subcutaneous procedure that leaves the heart and blood vessels untouched and intact.
Weight-loss supplements may cause life-threatening cardiac complications or death
Study published in the HeartRhythm Journal reveals hidden heart health risks associated with ingredients found in diet pills.
Presence of a wide and large S-wave in lead I is a powerful predictor...
New research published in the Journal of the American College of Cardiology indicates that a wide/and or large S-wave in lead I is a powerful predictor of life-threatening ventricular arrhythmias in Brugada Syndrome patients with no history of cardiac arrest at presentation.
Zoll LiveVest wearable defibrillator receives FDA approval for paediatric use
LiveVest is now approved for use by certain children who are at risk for sudden cardiac arrest, but who are not candidates for an implantable defibrillator device
University of Washington to lead US expansion of Medtronic’s HeartRescue project
HeartRescue is a Medtronic Philanthropy partnership launched in five US states in 2010, which aims to improve Sudden Cardiac Arrest (SCA) survival rates.
Zoll ResQCPR system receives premarket approval from the FDA
The ResQCPR system demonstrated a 49% increase in one-year survival in adult patients who experienced out-of-hospital cardiac arrest of presumed cardiac etiology, as compared to treatment with conventional manual CPR.
New data illustrate long-term safety and effectiveness of Boston Scientific S-ICD system
The interim analysis of the ongoing EFFORTLESS S-ICD registry, which evaluated 456 patients with a mean follow-up of 558 days, is the first real-world study to date and confirms the clinical benefits of the S-ICD System in a broad range of patients at risk of sudden cardiac arrest.
Sports and arrhythmias: to screen or not to screen
Screening athletes for the risk of sudden cardiac arrest has been a topic of discussion for many years. Jacob Tfelt-Hansen, author of a Danish study on this subject, gave an overview about different positions and studies that favour or disfavour this practice.
An approach to patient education and raising greater awareness of heart rhythm disorders
The Heart Rhythm Society has several campaigns to raise awareness of heart rhythm disorders, such as "Arrest the Risk Awareness" that aims to raise awareness of sudden cardiac arrest among black and Hispanic communities. Anne Gillis reviews the importance of patient education.
Boston Scientific launches new implantable defibrillation lead in Europe and Asia
The Reliance 4-Front lead is designed to streamline surgical procedure for treatment of heart failure and sudden cardiac arrest.
Global and inferior J wave amplitudes associated with recurrent ventricular fibrillation
According to a study presented by Laurent Roten, Bordeaux, France, at Cardiostim, in patients with early repolarisation and who had survived a sudden cardiac arrest, global and inferior J wave amplitudes were significantly higher in patients with recurrent ventricular fibrillation than in the remaining patients.
Philips launches SaveLives.net
The Save Lives website is an online campaign to inform people about sudden cardiac arrest and to empower them to act.
Long-term Medtronic device registry shows how implantable devices work in clinical practice
OMNI study showed that one out of six patients with defibrillators to prevent sudden cardiac arrest received lifesaving medical therapy within a period of two years following their implant.
Jewel IDE reports positive results for wearable cardioverter defibrillator
Element Science has announced the successful completion and presentation of the results of the Jewel investigational device exemption (IDE) study, assessing the Jewel patch-wearable...
US FDA grants Medtronic approval for extravascular defibrillator to treat abnormal heart rhythms
Medtronic has received US Food and Drug Administration (FDA) approval for the Aurora EV-ICD MRI SureScan (extravascular implantable cardioverter-defibrillator) and Epsila EV MRI SureScan defibrillation...
Medtronic issues Class I recall of ICD and CRT-D devices
Medtronic is recalling all implantable cardioverter defibrillator (ICD) and cardiac resynchronisation (CRT-D) devices manufactured after 2017 with a glassed feedthrough, as there is a...
Anxiety affects high proportion of patients with an ICD
Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first year while depression affects one in five,...
Impulse Dynamics announces first implantation of combined CCM and ICD device
Impulse Dynamics has today announced the completion of the first implantation for the INTEGRA-D clinical trial, designed to evaluate the safety and efficacy of...
Medtronic receives CE mark for EV-ICD device to treat “dangerous” heart rhythms
Medtronic has received CE mark for the Aurora extravascular implantable cardioverter-defibrillator (EV-ICD) magnetic resonance imaging (MRI) SureScan device and Epsila EV MRI SureScan defibrillation...
ESC 2022: Favourable results for Medtronic’s EV ICD system in pivotal study
Medtronic has announced that its investigational EV ICD system—a defibrillator with the lead placed under the breastbone, outside of the heart and veins—achieved a...
Catheter ablation “economically attractive” compared to drug therapy for AF
Catheter ablation of atrial fibrillation (AF) was economically attractive compared with drug therapy in the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial...
Racial minorities less likely to receive CPR
Black and Hispanic individuals experiencing a cardiac arrest either at home or in public are substantially less likely to receive cardiopulmonary resuscitation (CPR) from...
Cardiologs’ AI receives FDA clearance for paediatric use
Cardiologs announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to use its AI-powered cardiac diagnostics platform for...
ESC 2021: Drones touted as the future of defibrillator delivery
The world’s first feasibility study has found that drones can be used to deliver defibrillators to people with suspected cardiac arrest in the community....
CABANA trial shows favourable results for catheter ablation among ethnic minority patients
Among racial or ethnic minority patients enrolled in the North American cohort of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation)...
Cardiomatics partners for tool to analyse ECG signals from paediatric patients
Cardiomatics and the Medical University of Warsaw, Warsaw, Poland are developing a tool for automatic assessment, analysis, and interpretation of electrocardiographic signals (ECG) from...
Putting the patient at the centre of the AF treatment strategy
This article was sponsored by Biosense Webster
Putting the patient at the centre of the discussion is vital to setting the right strategy for the...
HeartHero receives CE mark for automated external defibrillator device
HeartHero has announced that its automated external defibrillator (AED) device—known as Elliot—has received CE mark approval. In a press release, the company said that...
Twin studies demonstrate the evolving S-ICD evidence-base
This advertorial has been sponsored by Boston Scientific
Two landmark studies have been published in 2020 following the use of subcutaneous implantable cardioverter defibrillator (S-ICDs)...
Tenfold risk of arrhythmias in intensive care COVID-19 patients
Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalised COVID-19 patients to suffer cardiac...
Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external...
Royal Philips has announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted premarket...
HRS 2020 Science: Packer assesses CABANA’s legacy
As part of this year’s HRS 2020 Science virtual event Douglas L Packer (Mayo Clinic, Rochester, USA) delivered the 2020 Eric N Prystowsky lecture...
Medtronic receives US FDA approval for Cobalt and Crome implantable ICDs
Medtronic has received US Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy-defibrillators (CRT-D).
ICDs monitor...
COVID-19: American Heart Association issue pandemic CPR guidelines
The American Heart Association (AHA) has compiled interim CPR guidelines to help rescuers treat cardiac arrest patients with suspected or confirmed COVID-19. The guidelines...
KardiaMobile 6L can be used to measure QT duration in COVID-19 patients
AliveCor has announced that its KardiaMobile 6L is now allowed for use in the measurement of a patient’s QTc and detection of potentially dangerous...
Medtronic receives CE Mark for Cobalt and Crome implantable ICDs
Medtronic has received CE Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor heart rhythms...
Biosense Webster launches initiatives to tackle atrial fibrillation
Biosense Webster, a Division of Johnson & Johnson, has reaffirmed its commitment to tackling atrial fibrillation (AF) by launching two major initiatives to coincide...
Prediction model of individual arrhythmic risk in ARVC can be used for primary prevention
Primary prevention of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging; Cynthia James explains how she and colleagues developed a model for...
Confirm Rx ICM allies with SharpSense technology and syncs to a smartphone for a...
Disclaimer: Advertorial sponsored by Abbott
Launched in May 2019 by Abbott, the next-generation Confirm Rx™ insertable cardiac monitor (ICM) has both the CE Mark in...
Patients with implantable cardioverter defibrillators do not adhere to driving restrictions
Jenny Bjerre outlines the results of a study presented at the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France) which...
ESC 2019: Catheter ablation may be up to 10 times more effective than drug...
Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
CABANA finds reduced AF and better quality of life after ablation but no reduction...
Catheter ablation for atrial fibrillation leads to a reduction in atrial fibrillation, better quality of life and lower hospitalisations than medical therapy, but does...
Is CABANA a positive or negative trial?
Several treatment options are available for atrial fibrillation (AF), including pharmacological rate or rhythm control, and catheter or surgical ablation. However, consensus as to...
Simultaneous TAVI and left atrial appendage closure is feasible
Thomas S Gilhofer (University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland) and others report in Structural Heart that a combined procedure...
More than 100,000 people now know hands-only CPR thanks to AHA programme
More than 100,000 people have been trained in hands-only cardiopulmonary resuscitation (CPR) since the American Heart Association (AHA) launched its hands-only CPR training kiosk...
Call for paradigm shift to CPR competency to save 50,000 additional lives each year...
The American Heart Association (Association) and Laerdal Medical (Laerdal) are furthering their decades-long alliance to deliver a new standard of resuscitation quality and patient...
Wearable defibrillators may be an alternative to surgically implanted device for children with certain...
Wearable cardioverter defibrillators – vest-like devices that deliver electric shocks to interrupt a dangerous heart rhythm – may be a safe and effective alternative...
CABANA trial provides important new data on clinical and quality of life effects of...
Catheter ablation for atrial fibrillation (AF) produced no significant improvement in death, disabling stroke, serious bleeding, or cardiac arrest but did reduce death or...
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online in EP Europace1, a...
Medtronic: class I recall- manufacturing error preventing electrical shock delivery
Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds) due to a defect in the manufacturing process. This defect...
Class I recall: HeartStart MRx defibrillator by Philips Electronics
Philips is recalling the HeartStart MRx defibrillator due to a defect in the device's gas discharge tube. The gas discharge tube has micro cracks...
85% of uninsured patients hospitalised for acute MI face catastrophic costs
Acute myocardial infarction (MI) and stroke patients without medical insurance in the USA face “devastating” and catastrophic health expenses that can bankrupt them, new...
CPR and emergency cardiovascular care awareness needed for women, children, and Latinos
Presenters at the American Heart Association (AHA)’s annual Scientific Sessions (11-15 November 2017; Anaheim, USA) have identified the lack of awareness of automated external...
Internists and geriatricians have insufficient understanding of implantable cardioverter defibrillator use
Physicians in internal medicine and geriatrics and even physicians working in cardiology departments lack basic knowledge of treatment with implantable cardioverter defibrillators (ICDs) and...
Research argues requirements for AEDs in US schools need improvement
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed in schools, yet only 17 out of 50 US...
Coffee shops and cash machines ideal locations for lifesaving automated external defibrillators
Community coffee shops and cash machines might be ideal locations for public access to automated external defibrillators, according to new research published in Circulation.
An...
Latest statistics show heart failure on the rise
The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...
High survival rates for elderly patients with implantable defibrillators
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80% survived two...
Seth J Worley
Seth J Worley (senior consultant, Cardiac Rhythm Device Management, MedStar Heart & Vascular Institute at MedStar Washington Hospital Center, Washington, DC, USA) considers that...
Heart Rhythm Congress (HRC) calls for urgent action to prevent thousands of unnecessary deaths...
Heart Rhythm Congress (HRC), the UK’s largest educational congress devoted solely to heart rhythm disorders will gather over 3,000 heart rhythm experts and healthcare...
Study validates new in-hospital mortality risk model for heart attack patients
The ACTION Registry-GWTG in-hospital mortality risk model for heart attack patients has been updated to include cardiac arrest, and validated as a robust instrument...
Digital strategies show promise for emergency heart and stroke care
Mobile devices, social media, visual media and crowdsourcing have the potential to improve emergency care for cardiac arrests, heart attacks and strokes, according to...
Etienne Aliot
Etienne Aliot (Nancy, France) has always been fascinated by the work of surgeons. This fascination set him on his path through medical school. He...
EFFORTLESS long-term study confirms safety and efficacy of Boston Scientific Subcutaneous Implantable Defibrillator
Data collected from the EFFORTLESS study were presented as a late-breaking clinical trial at the 37th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in San Francisco, USA.
Boston Scientific receives CE mark for MRI labelling of Emblem S-ICD system
Boston Scientific has received CE mark approval for the new Emblem MRI subcutaneous implantable defibrillator (S-ICD) system, as well as magnetic resonance (MR) conditional labelling for all previously implanted Emblem S-ICD systems.
Two studies report on missed opportunities to avoid painful shocks at the end of...
Many patients who have an implantable cardioverter defibrillator (ICD) are unaware that the device can be deactivated to prevent painful shocks in their final days of life, according to two new studies.
Zoll receives approval to market Thermogard XP in Japan
Zoll Medical has announced that its Japanese subsidiary, Asahi Kasei Zoll Medical, has obtained approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) to market the company's Thermogard XP.
Partners of heart defibrillator patients more concerned about resuming sex
Concerns for both patients and their partners declined after three months.
New recommendations green-light some athletes with heart disease to compete in competitive sport
The recommendations from the American Heart Association and the American College of Cardiology may permit participation in competitive sports for some athletes with long QT syndrome
Psychological implications and management for patients with implantable cardioverter defibrillators
The implantation of an implantable cardioverter defibrillator (ICD) device poses numerous psychosocial challenges, which have been shown to significantly influence functional outcomes in this population. Therefore, the optimisation of medical therapy and provision of psychological support is key to managing the patient's biopsychosocial functioning, write Elizabeth Banwell, Katie Murray and Stephen Gunning.
Physio-Control to acquire HeartSine
Financial details of the transaction are not being released. The combination creates one of the world's largest AED solutions providers.
First MRI-conditional implantable cardioverter defibrillator system receives FDA approval
Medtronic has announced that it has received the first US Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator (ICD) system for use with magnetic resonance imaging (MRI) scans.
ESC announces hot line sessions highlights
Key topics from the hot line sessions of ESC 2015 include atrial fibrillation, pacing, acute myocardial infarction, heart failure, hypertension, diabetes mellitus, pharmacology and coronary artery disease.
Less than 10% of eligible older patients receive an ICD after a myocardial infarction
Sean D Pokorney (Durham, USA) and others report in JAMA that only 8.1% of older patients who are eligible to receive an implantable cardioverter defibrillator (ICD) after a myocardial infarction actually do so. The authors also found that older age did not appear to affect the mortality benefit that is associated with ICD implantation.
No additional shocks or hospitalisations: Study shows home exercise safe after ICD
The results of a prospective, randomised trial demonstrate that moderately strenuous aerobic exercise, performed at home, for a select group of implantable cardioverter defibrillator (ICD) recipients was highly beneficial at improving cardiovascular performance. Importantly, the exercise did not compromise safety.
Long-term data show safety and efficacy of Boston Scientific’s S-ICD System
The S-ICD System was shown to convert more than 98% of heart arrhythmias that can lead to sudden death. These data are comparable to efficacy outcomes found in transvenous ICD (TV-ICD) clinical trials (95-99%).
Boston Scientific announces FDA and CE mark approval of the Emblem S-ICD system
The Emblem S-ICD system is 19% thinner and is projected to last 40% longer than the previous system, improving patient comfort and cosmetic outcomes while reducing the number of times the device will require replacement.
Ambulance-drone: A new way to deliver automated defibrillators
Alec Momont (graduate student, Technical University of Delft IDE, The Netherlands) has designed an ambulance-drone capable to deliver defibrillation to cardiac arrest victims in...
Philips’ defibrillators to be made available to schools across the UK
Philips secures nationwide Department for Education tender to provide schools with the latest HeartStart FRx automated external defibrillators.
S-ICD system receives favourable US coding and payment designations for 2015
Boston Scientific has announced that its subcutaneous implantable defibrillator (S-ICD System) will have designated Current Procedural Terminology (CPT) Category I codes by the American Medical Association, effective 1 January 2015.
Continuous ECG surveillance of marathon athletes is feasible
Online electrocardiogram (ECG) continuous surveillance during marathon running is feasible, according to a study presented at the European Congress on e-Cardiology and e-Health (29-31 October, Bern, Switzerland). The proof-of-concept study may allow "instantaneous diagnosis of potentially fatal rhythm disorders" in endurance athletes.
AHA and ACC release scientific statement on congenital and genetic heart disease screening
The American Heart Association (AHA) and American College of Cardiology (ACA) have released a statement including 14 key elements that can be used as a checklist for screening young people age 12-25 for congenital and genetic heart disease.
Wearable defibrillator registry (WEARIT-II) update
At Cardiostim/EHRA Europace (18-21 June, Nice, France), Ilan Goldenberg presented an update on one-year follow-up results from the prospective WEARIT-II registry of 1,404 patients using the Lifevest wearable cardioverter defibrillator (Zoll) who were enrolled in the USA from August 2011 through December 2013.
New data show that defibrillators programmed to wait longer to deliver therapy are safe...
Medtronic has announced the results from the first prospective randomised clinical trial to show that Medtronic implantable cardioverter defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary prevention patients.
New expert consensus statement attempts to close the gap on guidance for ICD therapy...
The expert consensus statement provides first-of-its-kind guidance on ICD therapy for the management of patient populations who are not well represented in clinical trials and, as a result, not specifically included in existing guidelines.
Richard Fogel
Richard Fogel, president-elect of the Heart Rhythm Society and chief executive officer at St Vincent Medical Group, considers he entered the field of electrophysiology at "the perfect time" when radiofrequency ablation and implantable cardiac defibrillators were emerging as a therapy to treat cardiac rhythm disorders. He spoke with Cardiac Rhythm News about this work, his interests in research and policy and the highlights of this year's Heart Rhythm Society's scientific sessions.
NICE consults on draft updated recommendations on implantable devices for the treatment of life-threatening...
The draft guidance from the UK's National Institute for Health and Care Excellence (NICE) defines which implantable cardiac devices are clinically and cost effective options for people with life-threatening arrhythmias or heart failure.
Next-generation X4 quadripolar CRT-D systems are CE-marked
Boston Scientific has announced it has received CE mark approval of its X4 line of quadripolar CRT-D systems including Autogen X4, Dynagen X4, and Inogen X4 cardiac resynchronisation therapy defibrillators (CRT-Ds), a suite of Acuity X4 quadripolar left ventricular (LV) leads and the Acuity Pro lead delivery system.
FDA issues safety communication on HeartStart automated external defibrillators
Certain HeartStart automated external defibrillator (AED) devices made by Philips Healthcare may be unable to deliver needed defibrillator shock in a cardiac emergency situation, the US Food and Drug Administration (FDA) has announced.
British Heart Foundation awards Zoll a tender for automated external defibrillators for another three-year...
On 17 July, Zoll Medical announced that it has been selected as a nominated supplier by the British Heart Foundation (BHF) for the Zoll AED Plus through 2016.
Researchers find a new possible cause of sudden infant death
Researchers in USA and Australia have found a new potentially treatable cause of sudden infant death, consisting of idiopathic ventricular fibrillation preceded by ST segment changes and QRS widening.
Elderly people benefit from using implantable defibrillators
Elderly people may benefit from implantable cardioverter defibrillators as much as younger people, according to new research published in Circulation.
Consensus statement on inherited primary arrhythmias syndromes released
Three scientific societies present the first comprehensive recommendations on patients with inherited arrhythmias at Heart Rhythm 2013
Myocardial fibrosis may be an independent predictor of malignant ventricular arrhythmia
Researchers in the United Kingdom have found in a first-of-its-kind study that fibrosis detected by late gadolinium enhancement cardiac MRI may be an independent predictor of hard cardiovascular events in patients with ventricular arrhythmias.
Fully Automatic AED Plus granted FDA 510(k) clearance
The new fully automatic unit provides all the same Full-Rescue features and benefits as the semiautomatic version of the AED Plus except that a shock is delivered automatically if one is advised.
Defibrillator manufacturer signs pledge to make patient data available to reduce preventable deaths
ZOLL Medical has announced that ZOLL is the first major defibrillator manufacturer to publicly pledge the sharing of patient data to reduce preventable deaths.
FDA clears Lifeline PRO and Lifeline ECG automated external defibrillators
These external defibrillators feature a revolutionary color LCD video display and 3-lead ECG monitoring capability.
Lifeline Auto automatic external defibrillator cleared for sale in the USA
The fully automatic external defibrillator system, which has been developed by Defibtech, was designed to provide a shock automatically when a heart arrhythmia is detected.
ECG screening has limited life-saving potential and would result in “staggering costs”
According to a study published in the Journal of the American College of Cardiology, a 20-year ECG screening programme of young athletes would only save 4,813 lives and would cost between US$51 billion and US$69 billion-resulting in enormous costs per life saved.
Assura implantable defibrillators get the CE mark approval
The Assura devices including the Quadra Assura CRT-D, the Unify Assura CRT-D and the Fortify Assura ICD, all from St Jude Medical, feature three new algorithms, more power and extended longevity.
HeartSine Samaritan public access defibrillator 300/300P shows battery problems
HeartSine has notified that certain Samaritan 300/300P public access defibrillators (PAD) have been found to intermittently turn on and off, which may eventually deplete the battery.
Philips to provide defibrillators on KLM and Air France’s passenger flights
According to a company release, the HeartStart FRx AED has been tested and certified for airline use and does not interfere with airplane electronics.
Anne Gillis
Anne Gillis, current president of the Heart Rhythm Society (HRS), talked to Cardiac Rhythm News about her career achievements, her plans for the HRS and the role of the society to encourage women into electrophysiology.
EPIC Alliance of female electrophysiologists session highlights at ESC
Sabine Ernst, Silvia G Priori, Andrea Russo, among other well-known female electrophysiologists presented research focused on gender specific topics at the ESC Congress in Munich, Germany.
Chu-Pak Lau
Chu-Pak Lau, honorary clinical professor, Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, talked to Cardiac Rhythm News about rate-responsive pacemakers, the potential role of gene therapy in managing atrial fibrillation, and leadless pacing.
Zoll to showcase its LifeVest wearable defibrillator at Cardiostim
Zoll, manufacturer of the LifeVest wearable defibrillator and the RecueNet Medgate 12-Lead management solution, will display its products at Cardiostim (13-16 June, Nice, France) this week
Anne Gillis: new president of the Heart Rhythm Society
The announcement was made at the Presidents' Reception on Friday 11 May. Gillis now serves as the 34th president of HRS and the second international president preceded by Bernard S Goldman, (1982-1983).
Cameron Health’s S-ICD System meets primary safety and efficacy endpoints in IDE clinical study
Martin C Burke, University of Chicago, USA, presented the results of the S-ICD System investigational device exemption clinical trial at a late-breaking session at the Heart Rhythm Society's 33rd Annual Scientific Sessions (9-12 May, Boston, USA).
Defibtech Introduces TSO-authorised aviation battery for Lifeline View AED
The long-life battery provides for eight hours of continuous operation to monitor and document a patient's ECG during a flight, and to provide defibrillation shocks as required.
Medtronic receives FDA approval to treat mildly symptomatic heart failure patients through expanded indication...
The FDA's decision was supported with data from the pivotal REVERSE and landmark RAFT clinical trials, which showed that CRT-D can benefit mildly symptomatic heart failure patients by reducing mortality and heart failure hospitalisation rates.
Boston Scientific to Acquire Cameron Health
Cameron Health is the developer of the world's first and only commercially available subcutaneous implantable cardioverter defibrillator - the S-ICD system.
Sodium channel blocker test has poor prognostic value in asymptomatic patients with non-diagnostic, Brugada...
A study published online in the HeartRhythm Journal indicates that while the sodium channel blocker test has good prognostic value in symptomatic patients with non-diagnostic Brugada ECG (Br-ECG), it appears to have little value in asymptomatic patients.
Angelo Auricchio
Angelo Auricchio, president of the European Heart Rhythm Association, reviews the highlights of his impressive career with Cardiac Rhythm News.
Cameron Health submits PMA application to FDA for the S-ICD system
The premarket application (PMA) submission included data from a 330-patient pivotal IDE clinical study which evaluated the safety and efficacy of the S-ICD system in patients at risk of sudden cardiac death.
1000th patient implanted with world’s only completely subcutaneous implantable defibrillator
Lara Dabiri Abkenari, in association with Luc Jordaens at the Erasmus Medical Center in Rotterdam, The Netherlands implanted the 1000th patient with the S-ICD system (Cameron Health).
Dutch experience deems totally subcutaneous ICD “viable alternative”
The subcutaneous implantable cardiac defibrillator (S-ICD) system is a viable alternative to conventional ICD systems for selected patients, results from a Dutch experience have shown.
VT/VF inducibility is not a predictor of arrhythmic events in Brugada syndrome, study shows
A multicentre, prospective study confirms lack of predictive accuracy of ventricular tachycardia/ventricular fibrillation (VT/VF) inducibility and identifies novel risk indicators for arrhythmic events in Brugada patients. Results of the PRELUDE registry were presented at Hearth Rhythm 2011, San Francisco, USA.
No overall survival benefit for ICDs inserted within 40 days after infarction
Despite major advances during the past two decades in the management of patients with acute myocardial infarction, sudden cardiac death remains an important contributor to overall mortality, according to Reginald Liew, National Heart Centre, Singapore.
Peter Schwartz
Peter Schwartz tells Cardiac Rhythm News about loving his research, being best man at a patient's wedding and having an article about golf published in a medical journal.
Mayo Clinic first in USA to use newly approved FDA technology to treat atrial...
"This approach provides a single ablative means of eliminating problematic atrial fibrillation in patients who failed drug therapy," said Douglas Packer, cardiologist at Mayo Clinic.
Implanted devices as effective in “real world” as in clinical trial settings
Study published in Circulation showed that, after one year, 92% of ICD recipients and 88% of CRT-D patients were alive. Survival rates after five years were 68% for ICD and 54% for CRT-D.
Lifevest selected as one of the top five medical devices of 2009
Dot Medical hails the Wearable Defibrillator as one of "technologically exceptional".
Entirely subcutaneous ICD treats ventricular arrhythmias
Gust H Bardy believes S-ICDs to prove a "viable alternative" to the transvenous system.
Cambridge Heart completes development of new MTWA Module
CEO praises technological advances in the module's development.
MADIT-RIT enrols first patients
The clinical trial, sponsored by Boston Scientific, was designed to determine which programming strategy best minimises the occurrence of unnecessary therapy in ICD and CRT-D patients.
Riccardo Cappato
Riccardo Cappato, from Milan, Italy, spoke to Cardiac Rhythm News about his career, advances in cardiac rhythm management, and his passion for crime fiction.
Mixed evidence on use of radiofrequency catheter ablation for AF
Report funded by the US Agency for Healthcare Research and Quality calls for more research on the effect of catheter ablation on quality of life.
Targeted drug therapy prevents exercise-induced arrhythmias
Researchers reported that flecainide can prevent potentially lethal arrhythmias in patients with a specific type of exercise or stress-induced arrhythmia disorder called CPVT.
Rhythm abnormality of unknown origin predicts sudden death risk
Researchers conducting a large study on sudden cardiac death were surprised to discover that a heart rhythm abnormality increased risk fivefold among patients with coronary artery disease.
HRS, ACC, and AHA publish guidance for electrophysiology during pandemic
The Heart Rhythm Society (HRS), The American College of Cardiology (ACC), and the American Heart Association (AHA) have released a joint document dealing with...
“No serious adverse outcomes” with ICD shocks in young athletes playing sport
A post-hoc analysis of the ICD Sports Registry—which has already indicated that many patients with implantable cardioverter defibrillators (ICD) can safely participate in vigorous...
CRT patients undergoing lead extraction are at no higher risk than non-CRT patients
Transvenous lead extraction in cardiac resynchronisation therapy (CRT) patients is not associated with increased 30-day mortality vs. non-CRT patients. The study found that age,...
Novel Ultraseal device is a feasible option for left atrial appendage closure
A feasibility study of a novel left atrial appendage device (Ultraseal, Cardia) indicates that the device is associated with a high rate of procedural...
Long-term sustained weight loss associated with significant reduction in AF burden
The first study investigating the long-term effects of weight loss and the degree of weight fluctuation on atrial fibrillation (AF) burden has found that obese patients with this arrhythmia who lost at least 10% of their body weight were six times more likely to achieve long-term freedom from atrial fibrillation.
Highlights Heart Rhythm Society Scientific Sessions 2014
John D Day, president-elect of the Heart Rhythm Society (HRS) and programme chair HRS Scientific Sessions 2014, talks to Cardiac Rhythm News about the...
Aggressive lifestyle management helps improve success rate after AF ablation
Researchers in Australia have found that aggressive management of cardiovascular risk factors and weight can dramatically impact the long-term success rate of freedom from atrial fibrillation following ablation.
New trial shows subcutaneous implantable cardioverter defibrillator is safe and effective
A new trial has found that the subcutaneous implantable cardioverter defibrillator (S-ICD System, Cameron Health/Boston Scientific) is safe and effective at detecting and treating both induced and spontaneous ventricular tachycardia and ventricular fibrillation in a broad range of patients requiring implantable cardioverter defibrillators (ICDs).
New findings for acute heart failure treatment with Trevena’s biased ligands
Trevena has announced the publication of new findings related to the mechanism of action of its Angiotensin II Type 1 Receptor (AT1R) biased ligands. The publication describes work led by R John Solaro, head of the Department of Physiology and Biophysics at the University of Illinois, Chicago, USA, performed in collaboration with Trevena scientists.
